A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
about
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
@en
type
label
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
@en
prefLabel
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
@en
P17
P6153
P131
P1476
A Randomized, Double-Blind, Pl ...... t Migraine - the CONQUER Study
@en
P17
P1813
CONQUER
@en
P3098
NCT03559257
P580
2018-07-31T00:00:00Z
P582
2019-06-19T00:00:00Z